Bank of Nova Scotia
AMGN icon

Bank of Nova Scotia’s Amgen AMGN Stock Holding History

Bank of Nova Scotia’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-500
Closed -$144K – 998
2023
Q4 		$144K Buy
+500
New +$136K ﹤0.01% 973
2016
Q1 		– Sell
-12,900
Closed -$2.09M – 708
2015
Q4 		$2.09M Buy
+12,900
New +$2.03M 0.01% 335

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of Nova Scotia's AMGN Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Amgen (AMGN) stake by 16% in Q1 2026, selling an estimated $20.9M and leaving 314,227 shares worth $111M. The position accounts for 0.19% of the portfolio, ranked #96.

Bank of Nova Scotia first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $127M in Q4 2021. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bank of Nova Scotia held 314,227 shares of Amgen worth $111M as of Q1 2026.
  • Bank of Nova Scotia sold 58,745 Amgen shares in Q1 2026, an estimated $20.9M.
  • Amgen made up 0.19% of Bank of Nova Scotia's portfolio in Q1 2026, its #96 holding.
  • Bank of Nova Scotia first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Bank of Nova Scotia's Amgen position peaked at $127M in Q4 2021.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.